|
BR122021024397A2
(enExample)
|
|
|
|
BR122021000189A2
(enExample)
|
|
|
|
BR112019008823A2
(enExample)
|
|
|
|
BR112020006084A8
(enExample)
|
|
|
|
BR122022025811B8
(enExample)
|
|
|
|
BR122022008542B1
(pt)
|
|
Uso de um composto e composição farmacêutica o compreendendo
|
|
BR122021023687A2
(enExample)
|
|
|
|
BR122021014832A2
(enExample)
|
|
|
|
BR122022003521A2
(enExample)
|
|
|
|
BR112020008820A2
(enExample)
|
|
|
|
BR202017020981U2
(enExample)
|
|
|
|
BE2017C035I2
(enExample)
|
|
|
|
BR102017014430A2
(enExample)
|
|
|
|
BR202017004898U2
(enExample)
|
|
|
|
BR102017003115A2
(enExample)
|
|
|
|
BR202017002937U2
(enExample)
|
|
|
|
BR202017002826U2
(enExample)
|
|
|
|
CN303996372S
(enExample)
|
|
|
|
CN303885159S9
(enExample)
|
|
|
|
CN303997205S
(enExample)
|
|
|
|
CN304000311S
(enExample)
|
|
|
|
CN303995600S
(enExample)
|
|
|
|
CN303949240S9
(enExample)
|
|
|
|
CN303948614S9
(enExample)
|
|
|
|
CN303943982S8
(enExample)
|
|
|